References

1. Fleming-Dutra C, Mabeyi C, Link-Gelles R, Alexandra N, Guh A, Forbes E. Streptococcus pneumonia serotype 15A in Psychiatric unit, Rhode Island, USA, 2010-201 Emerg Infect Dis. 2012Nov; 18(11):1889-93. PubMed | Google Scholar


2. Falade AG, Lagunju IA, Bakare RA, Odekanmi AA, and Adebgola RA. Invasive Pneumococcal disease in children >5 years Admitted to 3 urban hospitals in Ibadan, Nigeria. Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S190-6. PubMed | Google Scholar


3. Sahahidi N, Dahliwal J, Tyrell G, Hoang L, Patrick DM. Trends in Invasive Pneumococcal disease following introduction of the universal infant immunisation programme in BC. BCMJ. 2008; 50(1):18-21. PubMed | Google Scholar


4. Van Deursen AMM, Van Mens SP, Sanders EAM, Vlaminckx JMB, DeMelker HE, Schouls LM, DeGreeff SC. Invasive pneumococcal diseases and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infectr Dis. 2012; 18(11):1729-1737. PubMed | Google Scholar


5. Pilisvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201: 32-41. PubMed | Google Scholar


6. Pelton SI, Hout H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunisation of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007; 26: 468-72. PubMed | Google Scholar


7. Ladhiani SN, Slack MPE, Andrews NJ, Waight PA, Borrow R, Miller E. Invasive Pneumococcal Disease after routine Pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis. 2013;19(1):61-68. PubMed | Google Scholar


8. Cheesbrough M. Microbiology: in Medical Laboratory Manual for Tropical countries. ELBS edition. University Press Cambridge. 1996;32:26-58. PubMed | Google Scholar


9. Motayo BO, Akinduti P, Ogiogwa IJ, Akigbade OA, Aboderin BW, Adeyakinu F and Akinbo JA. Bacteriological profile of blood cultures from chidren with presumed septicaemia in a tertiary hospital in Abeokuta, Nigeria. Nature and Science. 2011;9(12):141-144. PubMed | Google Scholar


10. Clinical Laboratoy Standards Institute. Performance standards for Antimicrobial Disk susceptibility test. Wayne, PA. 2006; 26(1): 11-23. PubMed | Google Scholar


11. Cortese MM, Wolff M, Almeido HJ, Reid R, Ketcham J, Santosham M. High Incidence rates of Invasive Pneumococcal disease in the White Mountain Apache population. Arch Intern Med. 1992 Nov;152(11):2277-82. PubMed | Google Scholar


12. Sommer C, Resch B, and Simoes EAF. Risk factors for severe Respiratory Syncytial virus lower respiratory tract infection. Open Microbiol J. 2011; 5: 144-54. PubMed | Google Scholar


13. Akinduti PA, Oluwadun BA, Iwalokun BA, Oluwaseun E, and KO Onagbesan. Clonal dissemination of blaTEM β-lactamase strains among Enteric isolates in Abeokuta, Nigeria. Res J Microbiol. 2011;6(12):919-925. PubMed | Google Scholar


14. Motayo BO, Ogiogwa IJ, Aboderin BW, Okerentugba PO, Innocent-Adiele HC, Nwanze JC, Onoh CC, Okonko IO. Bacteriological Rewiew of Multi-Drug Resistance (MDR) pathogens involved in Respiratory tract infections (RTI) in Abeokuta, Nigeria. Researcher. 2012;4(5):49-55. PubMed | Google Scholar


15. Okonko IO, Soleye FA, Amusan TA, Ogun AA, Ogunusi TA, Ejembi J. Incidence of Multi-Drug Resistance (MDR) organisms in Sbeokuta, Southwestern, Nigeria. Global Journal of Pharmacology. 2009;3(2):69-80. PubMed | Google Scholar


16. Motayo BO, Akinduti PA, Adeyakinu AF, Okerentugba PO, Nwanze JC, Okonko IO. Antibiogram and Plasmid Profiling of Carbapenemase and Extended Spectrum β-Lactamase producing Eschericia coli and Klebsiella pnuemoniae in Abeokuta South Western, Nigeria. African Health Science in Press. 2013. PubMed | Google Scholar